<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[avandia Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/avandia.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to avandia]]></description>
	<s:counts start="0" returned="12" found="12" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Glaxo Gets an FDA Warning... With Teeth]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100010/glaxo-gets-an-fda-warning-with-teeth/]]></link>
		<description><![CDATA[Well before Vytorin became a cause cÃ©lÃ¨bre -- which is to say, about a year ago -- GlaxoSmithKline was the drugmaker getting slapped around by critics for downplaying or ignoring possible heart problems associated with its diabetes drug Avandia. That case, which led to new warnings on the drug's label...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sat, 12 Apr 2008 12:56:47 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/glaxo.html"><![CDATA[Glaxo]]></category>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
	</item>
	<item>
		<title><![CDATA[Top 10 medical stories of 2007]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4176/is_20080106/ai_n21190426]]></link>
		<description><![CDATA[1TOYING WITH Children's Health: 2007 was a tough year for children's health. Millions of toys were taken from babies' hands after being found to contain lead paint. Thousands of dolls and play sets were recalled because their defective designs allowed detachable magnets to become swallowing and choking hazards. At least...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 06 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/american+medical+association.html"><![CDATA[American Medical Association]]></category>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[food]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[researcher]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/stem-cell.html"><![CDATA[stem-cell]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Glaxo SmithKline to close plant.(PUERTO RICO)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6634/is_200712/ai_n26494914]]></link>
		<description><![CDATA[Drug maker GlaxoSmithKline PLC said it will close its plant in  Cidra, opened in 196, due to declining sales of drugs including the  diabetes treatment Avandia, reports AP (Oct. 24, 2007). The company will  transfer production of Avandia and the related drug Avandamet to other  facilities...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 01 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/associated+press.html"><![CDATA[Associated Press]]></category>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[Personal-injury lawsuits against GlaxoSmithKline Plc  to be]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4183/is_20071030/ai_n21091456]]></link>
		<description><![CDATA[Personal-injury lawsuits against GlaxoSmithKline Plc over its top- selling diabetes drug Avandia will be consolidated in a federal court in Philadelphia, a panel of judges concluded. The decision by the seven-member Judicial Panel of Multi-District Litigation came after lawyers argued last month in New York over the appropriate court for...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 30 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/lawsuit.html"><![CDATA[lawsuit]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[Diabetes drug Avandia increases heart attack risk: report]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200709/ai_n19508072]]></link>
		<description><![CDATA[WASHINGTON AFP &#8212; An analysis of four clinical trials involving more than 14,000 patients found that diabetes medication Avandia rosiglitazone taken over a lengthy period of time increases the risk of heart attack by 42 percent, a report released Tuesday said.  It marks one of the first studies to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 11 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CR Report: New Oral Diabetes Medicines No More Effective, Safe than Lower- Cost, Older Drugs]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200707/ai_n21906005]]></link>
		<description><![CDATA[To: MEDICAL EDITORSContact: Susan Herold of Consumer Reports Best Buy Drugs, +1-202- 462-6262 WASHINGTON, July 16 /PRNewswire-USNewswire/ -- Newer prescription drugs to treat type 2 diabetes -- including much-promoted Avandia and Actos -- are no more effective or safe than older drugs and cost significantly more, according to the latest...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 16 Jul 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/consumer+reports.html"><![CDATA[Consumer Reports]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Congress lambastes FDA over risks related to diabetes drug]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4176/is_20070607/ai_n19295229]]></link>
		<description><![CDATA[WASHINGTON -- Safety concerns about a GlaxoSmithKline diabetes drug prompted some Democratic lawmakers on Wednesday to rebuke the Food and Drug Administration and call for increased regulation of the pharmaceutical industry.    The controversy surrounding Glaxo's Avandia intensified when a medical expert told Congress that executives threatened to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/glaxo.html"><![CDATA[Glaxo]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Controversy spikes over anti-diabetes drug Avandia]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200706/ai_n19208740]]></link>
		<description><![CDATA[WASHINGTON AFP &#8212; Controversy over diabetes drug Avandia heated up Wednesday as experts pointed to studies linking it to greater heart attack risk, while a GSK study claimed rosiglitazone is safe.  The GlaxoSmithKline study published online Tuesday by the New England Journal of Medicine NEJM gave preliminary results of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 06 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/gsk.html"><![CDATA[GSK]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Rivals swoop in after report batters diabetes drug Avandia.(GlaxoSmithKline's drug Avandia increases heart-attack risk)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6398/is_200705/ai_n25581338]]></link>
		<description><![CDATA[Byline: RICH THOMASELLI    Byline: RICH THOMASELLI  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 May 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[Avandia users seek answers]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmusa/is_200705/ai_n19156138]]></link>
		<description><![CDATA[Many people with type 2 diabetes are wondering whether to keep taking their medication now that a new report suggests Avandia, a pill widely used to help control blood sugar, can raise heart attack risk.     As of Tuesday afternoon, the American Diabetes Association had fielded 70...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 23 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/american+diabetes+association.html"><![CDATA[American Diabetes Association]]></category>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/medication.html"><![CDATA[medication]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[GLAXOSMITHKLINE (GSK).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6602/is_200511/ai_n26019764]]></link>
		<description><![CDATA[GlaxoSmithKline GSK unveiled strong third-quarter results, with  EPS up 20 per cent on the year to 21.3p, boosted by disposal gains.  Pharmaceutical sales at the UK's largest drug company rose by 10  per cent to GBP4.7bn, with growth strong in the Adv  GlaxoSmithKline GSK unveiled strong...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 04 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline faces Chinese patent challenge.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6602/is_200408/ai_n26013931]]></link>
		<description><![CDATA[A group of Chinese generic drug manufacturers, believed to include  Shanghai Sunve and Chongqing Taiji, are to dispute  GlaxoSmithKline's patent for diabetes drug Avandia. A State  Intellectual Property Office hearing is set for 18 August - analysts  th  A group of Chinese generic drug manufacturers,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 06 Aug 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/avandia.html"><![CDATA[Avandia]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
</channel>
</rss>
